| Code | Description | Claims | Beneficiaries | Total Paid |
| 80053 |
Comprehensive metabolic panel |
7,904 |
6,707 |
$39K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
151 |
148 |
$38K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
617 |
522 |
$34K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
923 |
822 |
$29K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,257 |
7,986 |
$29K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,369 |
1,357 |
$27K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,369 |
1,357 |
$27K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
560 |
551 |
$23K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
488 |
474 |
$20K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
248 |
245 |
$19K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,906 |
1,875 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
471 |
439 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,292 |
2,232 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,392 |
1,717 |
$10K |
| 83735 |
|
2,783 |
1,858 |
$10K |
| 82803 |
|
746 |
481 |
$9K |
| 87510 |
|
601 |
592 |
$8K |
| 87480 |
|
600 |
591 |
$8K |
| 87081 |
|
2,415 |
2,346 |
$7K |
| 83605 |
|
1,218 |
970 |
$7K |
| 87040 |
|
708 |
621 |
$7K |
| 88307 |
|
89 |
76 |
$6K |
| 87660 |
|
750 |
738 |
$6K |
| 82962 |
|
2,736 |
1,712 |
$6K |
| 80061 |
Lipid panel |
1,499 |
1,485 |
$5K |
| 84484 |
|
959 |
849 |
$5K |
| 87641 |
|
248 |
234 |
$5K |
| 82330 |
|
621 |
338 |
$5K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
350 |
349 |
$5K |
| 88342 |
|
232 |
208 |
$4K |
| 83880 |
|
368 |
344 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
204 |
201 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
448 |
442 |
$4K |
| 87186 |
|
705 |
687 |
$4K |
| 85730 |
|
829 |
533 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
138 |
131 |
$3K |
| 86780 |
|
431 |
424 |
$3K |
| 83690 |
|
936 |
882 |
$3K |
| 86803 |
|
406 |
402 |
$3K |
| 84100 |
|
1,313 |
844 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
968 |
948 |
$3K |
| 86850 |
|
929 |
829 |
$3K |
| 80069 |
|
649 |
408 |
$3K |
| 81025 |
|
1,019 |
976 |
$3K |
| 82607 |
|
465 |
456 |
$3K |
| 85610 |
|
1,285 |
973 |
$3K |
| 88341 |
|
46 |
39 |
$2K |
| 81001 |
|
1,631 |
1,571 |
$2K |
| 88189 |
|
42 |
40 |
$2K |
| 86901 |
|
1,021 |
911 |
$2K |
| 84439 |
|
492 |
481 |
$2K |
| 86140 |
|
888 |
793 |
$2K |
| 80202 |
|
291 |
204 |
$2K |
| 85060 |
|
173 |
146 |
$2K |
| 86003 |
|
52 |
50 |
$2K |
| 82728 |
|
468 |
446 |
$2K |
| 84466 |
|
458 |
439 |
$2K |
| 86900 |
|
1,017 |
907 |
$2K |
| 82784 |
|
191 |
188 |
$1K |
| 82746 |
|
262 |
257 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
90 |
82 |
$1K |
| 83540 |
|
458 |
442 |
$1K |
| 87070 |
|
408 |
378 |
$1K |
| 85027 |
|
455 |
357 |
$1K |
| 87147 |
|
756 |
719 |
$1K |
| 87088 |
|
266 |
265 |
$1K |
| 81003 |
|
1,088 |
1,031 |
$1K |
| 85384 |
|
346 |
276 |
$1K |
| 82570 |
|
498 |
480 |
$1K |
| 86038 |
|
154 |
153 |
$1K |
| 87340 |
|
180 |
178 |
$1K |
| 83970 |
|
76 |
75 |
$1K |
| 84702 |
|
229 |
216 |
$1K |
| 85379 |
|
265 |
242 |
$991.94 |
| 82550 |
|
345 |
287 |
$989.20 |
| 82805 |
|
33 |
26 |
$951.17 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
108 |
97 |
$950.40 |
| 84703 |
|
245 |
241 |
$831.11 |
| 80047 |
|
177 |
88 |
$820.76 |
| 83615 |
|
298 |
255 |
$811.81 |
| 83516 |
|
117 |
115 |
$772.67 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
96 |
90 |
$745.75 |
| 85014 |
|
511 |
362 |
$679.76 |
| 85652 |
|
517 |
501 |
$636.91 |
| 86480 |
|
28 |
28 |
$597.36 |
| 82043 |
|
275 |
272 |
$506.56 |
| 87205 |
|
258 |
239 |
$497.26 |
| 82565 |
|
213 |
158 |
$476.10 |
| 84478 |
|
221 |
174 |
$468.93 |
| 87075 |
|
65 |
65 |
$454.05 |
| 82247 |
|
187 |
101 |
$450.79 |
| 84550 |
|
200 |
176 |
$405.61 |
| 84145 |
|
20 |
17 |
$400.05 |
| 82785 |
|
77 |
75 |
$366.34 |
| 80076 |
|
99 |
94 |
$366.32 |
| 83655 |
|
64 |
63 |
$349.92 |
| 82248 |
|
178 |
147 |
$344.92 |
| 85576 |
|
16 |
12 |
$316.71 |
| 86920 |
|
59 |
55 |
$310.20 |
| 87493 |
|
13 |
13 |
$297.83 |
| 85045 |
|
228 |
204 |
$290.39 |
| 85018 |
|
198 |
175 |
$256.36 |
| 86762 |
|
61 |
60 |
$255.91 |
| 86706 |
|
40 |
39 |
$242.73 |
| 84156 |
|
205 |
196 |
$228.88 |
| 88304 |
|
13 |
13 |
$226.24 |
| 84481 |
|
43 |
42 |
$215.06 |
| 87210 |
|
56 |
54 |
$211.50 |
| 82140 |
|
28 |
15 |
$163.20 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15 |
15 |
$157.96 |
| 85347 |
|
59 |
50 |
$140.95 |
| 84403 |
|
13 |
13 |
$132.72 |
| 86880 |
|
43 |
41 |
$129.05 |
| 80306 |
|
19 |
15 |
$113.81 |
| 86403 |
|
30 |
27 |
$103.80 |
| 86431 |
|
29 |
29 |
$87.06 |
| 84480 |
|
14 |
13 |
$66.92 |
| 80177 |
|
15 |
14 |
$62.52 |
| 83020 |
|
13 |
13 |
$56.03 |
| 84295 |
|
14 |
12 |
$44.27 |
| 84300 |
|
18 |
17 |
$38.16 |
| 82009 |
|
27 |
25 |
$38.00 |
| 82950 |
|
17 |
17 |
$31.49 |
| 89050 |
|
14 |
14 |
$24.51 |
| 84157 |
|
16 |
14 |
$21.00 |
| 81015 |
|
12 |
12 |
$14.42 |